MCMCB Pro
J0190

J0190Injection, biperiden lactate, per 5 mg

HCPCSTerminatedBETOS O1E

J0190 is a HCPCS Level II code for injection, biperiden lactate, per 5 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2025 and is not valid on new claims.

This code has been terminated

CMS terminated J0190 on December 31, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

The CMS record for J0190

Long descriptor
Injection, biperiden lactate, per 5 mg

The official wording. This is what the code means.

Short descriptor
Inj biperiden lactate/5 mg

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 1982

When CMS introduced the code.

Terminated
December 31, 2025

When CMS retired it.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J0190

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0190 is not quite right, the correct code is very often within a few positions of it.

  • J0174Lecanemab-irmb, for intravenous injection, 1 mg
  • J0175Injection, donanemab-azbt, 2 mg
  • J0177Injection, aflibercept hd, 1 mg
  • J0178Injection, aflibercept, 1 mg
  • J0179Injection, brolucizumab-dbll, 1 mg
  • J0180Injection, agalsidase beta, 1 mg
  • J0184Injection, amisulpride, 1 mg
  • J0185Injection, aprepitant, 1 mg
  • J0200Injection, alatrofloxacin mesylate, 100 mgterminated
  • J0202Injection, alemtuzumab, 1 mg
  • J0205Injection, alglucerase, per 10 unitsterminated
  • J0206Injection, allopurinol sodium, 1 mg
  • J0207Injection, amifostine, 500 mg
  • J0208Injection, sodium thiosulfate (pedmark), 100 mg
  • J0209Injection, sodium thiosulfate (hope), 100 mg
  • J0210Injection, methyldopate hcl, up to 250 mg

Questions about J0190

What is HCPCS code J0190?

J0190 is a HCPCS Level II code for injection, biperiden lactate, per 5 mg. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J0190?

The CMS HCPCS file marks J0190 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

Is J0190 still valid?

No. J0190 was terminated on December 31, 2025 and should not be used on new claims.

HCPCS Level II2026Q3-Jul· effective July 1, 2026